—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Grifols S.A. (GRF.MC) — the peer cohort

As of 2026-10-28 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Grifols S.A. ranks 13 of 13 in its cohort on the Closelooknet composite (51/100) — the cohort is led by BB Biotech AG at 74/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
GRF.MC Grifols S.A. 51 71 44 76 info 7.9%
ORNAV.HE Orion Oyj A 62 89 84 31 ok 1.6%
ORNBV.HE Orion Oyj B 62 89 84 31 ok 2.1%
SAN.PA Sanofi SA 58 55 69 59 watch 12.9%
AMGN Amgen Inc 56 89 84 40 bull 0.7%
NVO Novo Nordisk A/S 55 23 86 74 watch 37.5%
GSK GlaxoSmithKline PLC ADR 54 41 79 55 info 18.9%
ROVI.MC Laboratorios Farmaceuticos ROVI 62 33 77 50 info 28.1%
ALM.MC Almirall S.A. 53 30 46 63 info 24.5%
BION.SW BB Biotech AG 74 67 96 81 info 11.9%
HALO Halozyme Therapeutics Inc 73 98 94 38 ok 0.2%
DXCM DexCom Inc 65 77 80 38 bull 15.2%
UCB.BR UCB SA 65 66 70 53 info 6.1%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-28

Quick answers

Who are Grifols S.A.'s peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Orion Oyj A (ORNAV.HE), Orion Oyj B (ORNBV.HE), Sanofi SA (SAN.PA), Amgen Inc (AMGN), Novo Nordisk A/S (NVO), GlaxoSmithKline PLC ADR (GSK), Laboratorios Farmaceuticos ROVI (ROVI.MC), Almirall S.A. (ALM.MC) and others.

How does GRF.MC score against its peers?

Grifols S.A.'s composite reads 51/100, ranking 13 of 13 in its cohort as of 2026-10-28; the cohort's highest composite is BB Biotech AG at 74/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.